This study shows that TBN is a potent modulator of P-gp-mediated MDR, as shown by using both in vitro and in vivo a human MDR1 gene-transfected mouse lymphoma cell line and its parental doxorubicin-sensitive counterpart. The gene discussed is ABCB1; the disease is lymphoma.